Join our daily newsletter At The Bell to receive exclusive market insights
- A potential takeover of Ramsay Healthcare’s (RHC) 50:50 subsidiary, Ramsay Sime Darby Health Care, will not go ahead
- IHH Healthcare Berhad had made a conditional, non-binding indicative proposal to acquire the business in March, however, IHH has chosen not to make a binding proposal
- The JV between Ramsay Healthcare and Sime Darby was recently recognised with six healthcare and hospital awards in Asia Pacific, including hospital of the year for 2022
- Both parties are committed to the future success of the business and say it still stands in “good stead”
- RHC shares are down 1.69 per cent to trade at $69.86 just before market close
Discussions to purchase Ramsay Healthcare’s (RHC) 50 per cent owned joint venture, Ramsay Sime Darby Health Care, have ceased, marking the end of a potential takeover.
IHH Healthcare Berhad had made a conditional, non-binding indicative proposal to acquire 100 per cent of Ramsay Sime Darby announced on March 22, 2022.
However, discussions have now ceased, with Ramsay saying it did not result in a binding proposal.
Ramsay Sime Darby is a 50:50 joint venture between Ramsay Healthcare and Sime Darby Berhad, which Ramsay says was “recently recognised with six Global Health AsiaPacific Healthcare and Hospital Awards, including Hospital of the Year 2022.”
Both parties of the JV say they are “committed” to the business’s future success and believe it still stands in “good stead.”
RHC shares were down 1.69 per cent to trade at $69.86 just before market close.
